Skip to main content
Account

Peer review reports

From: Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial

Original Submission
20 Mar 2024 Submitted Original manuscript
6 Jul 2024 Reviewed Reviewer Report - Kirsty Loudon
12 Jul 2024 Author responded Author comments - Yun Hao
Resubmission - Version 2
12 Jul 2024 Submitted Manuscript version 2
Publishing
15 Jul 2024 Editorially accepted
19 Jul 2024 Article published 10.1186/s13063-024-08340-1

Learn about peer review

Back to article page

Navigation